Lupin

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE326A01037
  • NSEID: LUPIN
  • BSEID: 500257
INR
2,205.55
6.6 (0.3%)
BSENSE

Feb 10

BSE+NSE Vol: 5.6 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,205.55",
    "chg": 6.6,
    "chgp": "0.3%",
    "dir": 1,
    "prev_price": "2,198.95",
    "mcapval": "100,786.57 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE326A01037",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "5.6 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-buy-by-marketsmojo-3828394",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_mojoScore_3828394.png",
        "date": "2026-02-09 10:10:52",
        "description": "Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Lupin Ltd Gains 0.80%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-gains-080-4-key-factors-driving-the-weeks-momentum-3826468",
        "imagepath": "",
        "date": "2026-02-07 16:07:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens lower at Rs.2,128.60 amid broad market weakness</p>\n                    <p><strong>3 Feb:</strong> New 52-week high reached at Rs.2,249.3 following a strong gap up</p>\n                    <p><strong>5 Feb:</strong> Sharp 17.1% surge in open interest signals bullish positioning</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.2,168.35 after a 2.21% decline on the final trading day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,151.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-..."
      },
      {
        "title": "Lupin Ltd Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-3822616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_oi_spurts_by_underlying_3822616.png",
        "date": "2026-02-05 15:00:10",
        "description": "Lupin Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market interest and potential directional bets. The stock recently hit a new 52-week high of Rs 2,244.5, supported by robust volume and positive price momentum, reflecting growing investor confidence despite a backdrop of subdued sectoral performance."
      },
      {
        "title": "Lupin Ltd Sees Significant Open Interest Surge Amid Bullish Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-bullish-market-momentum-3822568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_oi_spurts_by_underlying_3822568.png",
        "date": "2026-02-05 14:00:11",
        "description": "Lupin Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market interest and potential directional bets. The stock recently hit a new 52-week high of Rs 2,244.5, supported by robust volume and positive price momentum, as investors recalibrate their positions amid evolving market dynamics."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-bullish-momentum-3822537",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_oi_spurts_by_underlying_3822537.png",
        "date": "2026-02-05 13:00:09",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock recently hit a new 52-week high of Rs 2,244.5, supported by rising volumes and sustained buying interest, reflecting bullish sentiment among traders and investors alike."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-bullish-momentum-3822487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_oi_spurts_by_underlying_3822487.png",
        "date": "2026-02-05 12:00:07",
        "description": "Lupin Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling heightened market activity and potential directional bets. The stock recently hit a new 52-week high of Rs 2,240, supported by robust volume and positive price momentum, reflecting growing investor confidence despite a backdrop of subdued sectoral and benchmark indices."
      },
      {
        "title": "Lupin Ltd. Opens Strong with Significant Gap Up, Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-opens-strong-with-significant-gap-up-reflecting-positive-market-sentiment-3818536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_gapup_3818536.png",
        "date": "2026-02-03 12:00:34",
        "description": "Lupin Ltd. commenced trading on 3 Feb 2026 with a significant gap up, opening 5.67% higher and touching a new 52-week high of ₹2,249.3. This strong start underscores positive market sentiment amid a broader sectoral uptrend in Pharmaceuticals & Biotechnology."
      },
      {
        "title": "Lupin Ltd. Hits Intraday High with 3.05% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-hits-intraday-high-with-305-surge-on-3-feb-2026-3818497",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_priceRelatedfactors_3818497.png",
        "date": "2026-02-03 11:51:11",
        "description": "Lupin Ltd. surged to a fresh 52-week high of Rs 2249.3 on 3 Feb 2026, marking a robust intraday performance with a gain of 5.67% from the previous close. The pharmaceutical giant’s stock demonstrated strong buying interest throughout the session, outperforming the broader Sensex and its sector peers."
      },
      {
        "title": "Lupin Ltd. Hits New 52-Week High at Rs.2249.3 Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-hits-new-52-week-high-at-rs22493-marking-significant-milestone-3818306",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_priceRelatedfactors_3818306.png",
        "date": "2026-02-03 10:39:43",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.2249.3 today, underscoring a notable rally and positive momentum in its stock performance. This milestone reflects the company’s sustained strength amid a dynamic market environment."
      }
    ],
    "total": 599,
    "sid": "641789",
    "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "04-Feb-2026",
      "details": "Lupin Launches Topiramate Extended-Release Capsules in the United States.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "02-Feb-2026",
      "details": "Lupin Launches Dasatinib Tablets in the United States.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "02-Feb-2026",
      "details": "Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>600%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Lupin Ltd Gains 0.80%: 4 Key Factors Driving the Week’s Momentum

2026-02-07 16:07:04

Key Events This Week

2 Feb: Stock opens lower at Rs.2,128.60 amid broad market weakness

3 Feb: New 52-week high reached at Rs.2,249.3 following a strong gap up

5 Feb: Sharp 17.1% surge in open interest signals bullish positioning

6 Feb: Week closes at Rs.2,168.35 after a 2.21% decline on the final trading day

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

04-Feb-2026 | Source : BSE

Lupin Launches Topiramate Extended-Release Capsules in the United States.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

02-Feb-2026 | Source : BSE

Lupin Launches Dasatinib Tablets in the United States.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

02-Feb-2026 | Source : BSE

Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

12 Feb 2026

stock-summary
DIVIDEND

Lupin Ltd. has declared 600% dividend, ex-date: 25 Jul 25

stock-summary
SPLITS

Lupin Ltd. has announced 2:10 stock split, ex-date: 27 Aug 10

stock-summary
BONUS

Lupin Ltd. has announced 1:1 bonus issue, ex-date: 11 Aug 06

stock-summary
RIGHTS

No Rights history available